Non-applicability of Annual Secretarial Compliance Report for the year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed BSE that the Annual Secretarial Compliance Report under SEBI Regulation 24A is not applicable to the company for FY2024-25. The company qualifies for the exemption because its paid-up equity share capital is Rs. 4 crore and net worth is around Rs. 4.68 crore, both well below the SEBI thresholds of Rs. 10 crore (capital) and Rs. 25 crore (net worth) that trigger this requirement. As a result, the company is not required to file this report for the year. This is a routine regulatory disclosure confirming an exemption, not a new compliance obligation.
No material impact on shareholders or the stock. This is a routine filing confirming that the company is small enough to be exempt from one specific governance reporting requirement, meaning slightly lower compliance costs but also fewer public disclosures on SEBI regulation adherence.